Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice

Erika Cretney(Peter MacCallum Cancer Centre), Kazuyoshi Takeda(Juntendo University), Hideo Yagita∥(Juntendo University), Moira Glaccum(IDEX Corporation (United States)), Jacques J. Peschon(IDEX Corporation (United States)), Mark J. Smyth(Peter MacCallum Cancer Centre)
The Journal of Immunology
February 1, 2002
Cited by 592Open Access
Full Text

Abstract

We have previously implicated TNF-related apoptosis-inducing ligand (TRAIL) in innate immune surveillance against tumor development. In this study, we describe the use of TRAIL gene-targeted mice to demonstrate the key role of TRAIL in suppressing tumor initiation and metastasis. Liver and spleen mononuclear cells from TRAIL gene-targeted mice were devoid of TRAIL expression and TRAIL-mediated cytotoxicity. TRAIL gene-targeted mice were more susceptible to experimental and spontaneous tumor metastasis, and the immunotherapeutic value of alpha-galactosylceramide was diminished in TRAIL gene-targeted mice. TRAIL gene-targeted mice were also more sensitive to the chemical carcinogen methylcholanthrene. These results substantiated TRAIL as an important natural effector molecule used in the host defense against transformed cells.


Related Papers

No related papers found

Powered by citation graph analysis